{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T10:51:17Z","timestamp":1777719077030,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,8,21]],"date-time":"2012-08-21T00:00:00Z","timestamp":1345507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1136\/annrheumdis-2012-201611","type":"journal-article","created":{"date-parts":[[2012,8,22]],"date-time":"2012-08-22T02:13:32Z","timestamp":1345601612000},"page":"1287-1294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial"],"prefix":"10.1016","volume":"72","author":[{"given":"Philip G","family":"Conaghan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Durez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rieke E","family":"Alten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd-R\u00fcdiger","family":"Burmester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul P","family":"Tak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Klareskog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anca Irinel","family":"Catrina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"DiCarlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corine","family":"Gaillez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Le Bars","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianhuang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Peterfy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2012-201611_bib1","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/1529-0131(199908)42:8<1706::AID-ANR20>3.0.CO;2-Z","article-title":"The relationship between synovitis and bone changes in early untreated rheumatoid arthritis: a controlled magnetic resonance imaging study","volume":"42","author":"McGonagle","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"5 Suppl 35","key":"10.1136\/annrheumdis-2012-201611_bib2","first-page":"S18","article-title":"New approaches to imaging early inflammatory arthritis","volume":"22","author":"Brown","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201611_bib3","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1136\/ard.2010.146068","article-title":"Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial","volume":"70","author":"Conaghan","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201611_bib4","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1002\/art.30592","article-title":"Significant improvement in synovitis, osteitis, and bone erosion following golimumab and methotrexate combination therapy as compared with methotrexate alone: a magnetic resonance imaging study of 318 methotrexate-naive rheumatoid arthritis patients","volume":"63","author":"Ostergaard","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201611_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/BOR.0b013e32832498f0","article-title":"The role of MRI in rheumatoid arthritis: research and clinical issues","volume":"21","author":"Freeston","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201611_bib6","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/art.23417","article-title":"Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial","volume":"58","author":"Cohen","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201611_bib7","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1002\/art.23055","article-title":"Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone","volume":"56","author":"Durez","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201611_bib8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/art.30114","article-title":"An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents","volume":"63","author":"Genovese","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"3(Suppl.","key":"10.1136\/annrheumdis-2012-201611_bib9","first-page":"152","article-title":"Rituximab (RTX) plus methotrexate (MTX) prevents bone erosion and joint-space narrowing (JSN) and reduces synovitis, osteitis as shown on MRI: Results from a randomised, placebo-controlled trial in patients (PTS) with rheumatoid arthritis (RA-score)","volume":"70","author":"Peterfy","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201611_bib10","first-page":"S51","article-title":"Decreased incidence of synovitis, osteitis, and erosion in early RA patients treated with adalimumab plus methotrexate compared to those with methotrexate alone: high-field MRI analysis from OPTIMA (Abstract 123)","volume":"62","author":"Peterfy","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201611_bib11","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.3899\/jrheum.110418","article-title":"Magnetic resonance imaging in rheumatoid arthritis clinical trials: emerging patterns based on recent experience","volume":"38","author":"Peterfy","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201611_bib12","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1136\/ard.2010.145268","article-title":"Sustained disease remission and inhibition of radiographic progression in methotrexate-naive patients with rheumatoid arthritis and poor prognostic factors treated with abatacept: 2-year outcomes","volume":"70","author":"Bathon","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 3):440","key":"10.1136\/annrheumdis-2012-201611_bib13","article-title":"Abatacept increases the proportion of patients who remain free from structural damage progression through 5 Years in methotrexate inadequate responders with RA.","volume":"68","author":"Genant","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201611_bib14","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1136\/ard.2007.085084","article-title":"Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial","volume":"67","author":"Genant","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201611_bib15","doi-asserted-by":"crossref","first-page":"865","DOI":"10.7326\/0003-4819-144-12-200606200-00003","article-title":"Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial","volume":"144","author":"Kremer","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1136\/annrheumdis-2012-201611_bib16","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1136\/ard.2010.139345","article-title":"Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial","volume":"70","author":"Kremer","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201611_bib17","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1136\/ard.2008.101121","article-title":"Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors","volume":"68","author":"Westhovens","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201611_bib18","first-page":"1385","article-title":"OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system","volume":"30","author":"Ostergaard","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201611_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/ard.2003.018457","article-title":"Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change","volume":"64","author":"Bruynesteyn","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201611_bib20","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1136\/ard.2008.091876","article-title":"Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study","volume":"68","author":"Buch","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201611_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/art.20712","volume":"52","author":"Quinn","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201611_bib22","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1002\/art.21493","article-title":"Reliability and sensitivity to change of the OMERACT rheumatoid arthritis magnetic resonance imaging score in a multireader, longitudinal setting","volume":"52","author":"Haavardsholm","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201611_bib23","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1136\/ard.2009.119016","article-title":"Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)","volume":"69","author":"Emery","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201611_bib24","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/art.30176","article-title":"Abatacept in the treatment of patients with psoriatic arthritis: results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial","volume":"63","author":"Mease","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201611_bib25","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/rheumatology\/kel137","article-title":"Bone oedema predicts erosive progression on wrist MRI in early RA\u2013a 2-yr observational MRI and NC scintigraphy study","volume":"45","author":"Palosaari","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2012-201611_bib26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/art.10747","article-title":"Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis","volume":"48","author":"Conaghan","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201611_bib27","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/ard.2009.123950","article-title":"MRI in early rheumatoid arthritis: synovitis and bone marrow oedema are independent predictors of subsequent radiographic progression","volume":"70","author":"Boyesen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201611_bib28","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/art.10084","article-title":"Comparative assessment of leflunomide and methotrexate for the treatment of rheumatoid arthritis, by dynamic enhanced magnetic resonance imaging","volume":"46","author":"Reece","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"Suppl 3","key":"10.1136\/annrheumdis-2012-201611_bib29","first-page":"98","article-title":"Tocilizumab redcues synovitis within 2\u2005weeks and pre-erosive osteitis within 12\u2005weeks in patients with RA: results from a multi-site low-field MRI study (Abstract OP0135)","volume":"69","author":"Troum","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 3","key":"10.1136\/annrheumdis-2012-201611_bib30","first-page":"152","volume":"70","author":"Peterfy","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201611_bib31","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/ard.2007.080002","article-title":"Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate","volume":"67","author":"Schiff","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 3","key":"10.1136\/annrheumdis-2012-201611_bib32","first-page":"SAT0284","article-title":"The relationship between MRI outcomes and clinical efficacy in abatacept-treated patients with rheumatoid arthritis (RA) and an inadequate response to methotrexate (MTX)","volume":"70","author":"Durez","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"10 Suppl","key":"10.1136\/annrheumdis-2012-201611_bib33","first-page":"S164","article-title":"Long-term safety profile of abatacept (Orencia) from the rheumatoid arthritis clinical trial program; integrated analysis of data from 12,132 patient\u2013years of exposure","volume":"62","author":"Hochberg","year":"2010","journal-title":"Arthritis & Rheumatism"},{"key":"10.1136\/annrheumdis-2012-201611_bib34","unstructured":"Alten R, Kaine J, Keystone E, et al. Safety of Subcutaneous Abatacept in Patients with Rheumatoid Arthritis (RA): Integrated Analysis of Five Clinical Trials up to 4.5 Years. Presented at EULAR, London, 25\u201328th May 2011. Poster SAT0292 2011."}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672421390X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672421390X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2012-201611","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T08:48:29Z","timestamp":1739522909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000349672421390X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S000349672421390X"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2012-201611","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2012-201611","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 \u00a9 2013 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}